The estimated Net Worth of Michael J Astrue is at least $4.67 Thousand dollars as of 4 September 2013. Michael Astrue owns over 10,000 units of VIVUS stock worth over $4,665 and over the last 20 years Michael sold VVUS stock worth over $0.
Michael has made over 2 trades of the VIVUS stock since 2005, according to the Form 4 filled with the SEC. Most recently Michael bought 10,000 units of VVUS stock worth $119,600 on 4 September 2013.
The largest trade Michael's ever made was buying 20,000 units of VIVUS stock on 20 May 2005 worth over $124,200. On average, Michael trades about 4,286 units every 433 days since 2005. As of 4 September 2013 Michael still owns at least 10,000 units of VIVUS stock.
You can see the complete history of Michael Astrue stock trades at the bottom of the page.
Michael's mailing address filed with the SEC is C/O TRANSKARYOTIC THERAPIES INC, 700 MAIN STREET, CAMBRIDGE, MA, 02139.
Over the last 21 years, insiders at VIVUS have traded over $6,261,269 worth of VIVUS stock and bought 5,180,746 units worth $13,074,554 . The most active insiders traders include Tide Capital, Llc North Tid..., Alexander J Denner, and Ernest Mario. On average, VIVUS executives and independent directors trade stock every 39 days with the average trade being worth of $35,394. The most recent stock trade was executed by John P. Amos on 1 March 2019, trading 11,000 units of VVUS stock currently worth $53,350.
VIVUS, Inc. engages in the development and commercialization of novel therapeutic products. The firm's products are indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and is headquartered in Campbell, CA.
VIVUS executives and other stock owners filed with the SEC include: